Sunitinib malate in patients with intermediate-2 or high-risk myelodysplastic syndrome or chronic myelomonocytic leukemia
Yee, Karen W. L., Storring, John M., Buckstein, Rena, Wells, Richard A., Xenocostas, Anargyros, Kovacs, Michael J., Howson-Jan, Kang, Wang, Eunice S., Battista, Kristina, Wang, Lisa, Oza, Amit M., IvyVolume:
55
Langue:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2014.900763
Date:
November, 2014
Fichier:
PDF, 127 KB
english, 2014